A detailed history of Carson Allaria Wealth Management, Ltd. transactions in Pfizer Inc stock. As of the latest transaction made, Carson Allaria Wealth Management, Ltd. holds 10,736 shares of PFE stock, worth $286,865. This represents 0.18% of its overall portfolio holdings.

Number of Shares
10,736
Previous 9,661 11.13%
Holding current value
$286,865
Previous $270,000 14.81%
% of portfolio
0.18%
Previous 0.17%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

BUY
$27.7 - $31.39 $29,777 - $33,744
1,075 Added 11.13%
10,736 $310,000
Q2 2024

Jul 22, 2024

SELL
$25.26 - $29.6 $1,490 - $1,746
-59 Reduced 0.61%
9,661 $270,000
Q1 2024

May 07, 2024

SELL
$25.89 - $29.73 $28,996 - $33,297
-1,120 Reduced 10.33%
9,720 $269,000
Q4 2023

Feb 08, 2024

BUY
$26.13 - $33.94 $23,151 - $30,070
886 Added 8.9%
10,840 $312,000
Q3 2023

Nov 09, 2023

SELL
$32.09 - $37.51 $66,715 - $77,983
-2,079 Reduced 17.28%
9,954 $330,000
Q2 2023

Aug 01, 2023

SELL
$36.12 - $41.79 $13,219 - $15,295
-366 Reduced 2.95%
12,033 $441,000
Q1 2023

Apr 26, 2023

BUY
$39.39 - $51.28 $2,599 - $3,384
66 Added 0.54%
12,399 $505,000
Q4 2022

Feb 06, 2023

SELL
$41.75 - $54.5 $2,713 - $3,542
-65 Reduced 0.52%
12,333 $632,000
Q3 2022

Nov 09, 2022

BUY
$43.76 - $53.42 $3,194 - $3,899
73 Added 0.59%
12,398 $543,000
Q2 2022

Aug 02, 2022

SELL
$46.53 - $55.17 $19,496 - $23,116
-419 Reduced 3.29%
12,325 $646,000
Q1 2022

May 05, 2022

SELL
$45.75 - $56.69 $86,010 - $106,577
-1,880 Reduced 12.86%
12,744 $660,000
Q4 2021

Feb 10, 2022

BUY
$41.32 - $61.25 $604,263 - $895,720
14,624 New
14,624 $864,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Carson Allaria Wealth Management, Ltd. Portfolio

Follow Carson Allaria Wealth Management, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Carson Allaria Wealth Management, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Carson Allaria Wealth Management, Ltd. with notifications on news.